The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of real-world evidence to benchmark clinical trial results: A case study in von Hippel-Lindau (VHL) disease.
 
W. Marston Linehan
No Relationships to Disclose
 
Cathy Anne Pinto
Employment - Merck Sharp & Dohme LLC, a subsidary of Merck & Co., Inc, Rahway, NJ USA
Stock and Other Ownership Interests - Merck; Merck Sharp & Dohme LLC, a subsidary of Merck & Co., Inc, Rahway, NJ USA
Travel, Accommodations, Expenses - Merck Sharp & Dohme LLC, a subsidary of Merck & Co., Inc, Rahway, NJ USA
Other Relationship - IMI PREFER Consortia
 
Yanfang Liu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Claire Fox
Employment - Merck
 
Ananya Roy
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Mengying Li
Employment - AstraZeneca (I); IQVIA
Consulting or Advisory Role - IQVIA (Inst)
 
Rafia Bosan
Employment - IQVIA
Consulting or Advisory Role - IQvia (Inst)
 
Mark Wayne Ball
No Relationships to Disclose
 
Kristin Choo
No Relationships to Disclose
 
Rabindra Gautam
No Relationships to Disclose
 
Deborah Nielsen
No Relationships to Disclose
 
Beth Ryan
Employment - Exact Sciences (I)
Stock and Other Ownership Interests - Exact Sciences (I)
 
Alexis Rompre-brodeur
Consulting or Advisory Role - Knight Pharmaceuticals
 
Cathy Vocke
No Relationships to Disclose
 
Rodolfo F. Perini
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ramaprasad Srinivasan
Research Funding - Genentech (Inst); Merck/Peloton (Inst); Nikang Therapeutics (Inst); Novartis (Inst)